SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-007351
Filing Date
2023-03-13
Accepted
2023-03-13 08:01:10
Documents
116
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2828491
2 form10-k_001.jpg GRAPHIC 33750
3 ex10-48.htm EX-10.48 90823
4 ex10-48_001.jpg GRAPHIC 2913
5 ex10-49.htm EX-10.49 23829
6 ex10-50.htm EX-10.50 246570
7 ex10-51.htm EX-10.51 46712
8 ex10-51_001.jpg GRAPHIC 36104
9 ex23-1.htm EX-23.1 3766
10 ex31-1.htm EX-31.1 18702
11 ex31-2.htm EX-31.2 18747
12 ex32-1.htm EX-32.1 5976
13 ex32-2.htm EX-32.2 6068
  Complete submission text file 0001493152-23-007351.txt   12044093

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE vbiv-20221231.xsd EX-101.SCH 83681
15 XBRL CALCULATION FILE vbiv-20221231_cal.xml EX-101.CAL 80650
16 XBRL DEFINITION FILE vbiv-20221231_def.xml EX-101.DEF 359596
17 XBRL LABEL FILE vbiv-20221231_lab.xml EX-101.LAB 605398
18 XBRL PRESENTATION FILE vbiv-20221231_pre.xml EX-101.PRE 491776
110 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1851618
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37769 | Film No.: 23725769
SIC: 2834 Pharmaceutical Preparations